Literature DB >> 35666332

Distal esophageal wall thickness correlates with dysphagia in adult patients with eosinophilic esophagitis.

Stephanie Wong1, Marcus Tippett1, Joshua Zobel1, Romina Safaeian1, Richard H Holloway1, Andrew Ruszkiewicz2,3,4,5, Nam Q Nguyen6,7.   

Abstract

BACKGROUND: Thickening of the esophageal wall in patients with eosinophilic esophagitis (EoE) and gastro-esophageal reflux disease (GERD) has been shown in studies using endoscopic ultrasound (EUS). We hypothesise that transmural inflammation in EoE results in prominent esophageal wall thickening compared with the mucosal inflammation in GERD. The aim of this study was to compare the relationship among dysphagia, endoscopic appearance, wall thickness, histology, and motility in EoE and GORD.
METHODS: EoE and GERD patients were prospectively studied between February 2012 and April 2021. Patients were studied on 2 separate occasions with endoscopy, EUS and mucosal biopsies, followed by high-resolution manometry. Epidemiology and dysphagia data were obtained.
RESULTS: A total of 45 patients (31 EoE, 14 GERD) were included. There were no significant differences in age, sex, duration of disease and presence of esophageal motility disorders. EoE patients had a higher dysphagia score (P < 0.001), EREFS score (P < 0.001) and peak eosinophil count (P < 0.001) compared with GERD patients. Thickness of the submucosa in the distal esophagus in EoE was significantly higher than GERD (P = 0.003) and positively correlated with duration of disease (P = 0.01, R = 0.67). Positive correlation was also found between dysphagia score and distal total esophageal wall thickness (P = 0.03, R = 0.39) in EoE patients. No correlation was found between these variables in GERD patients.
CONCLUSION: Distal esophageal wall thickness positively correlates with dysphagia score in EoE but not GERD. This appears to be related to the composition of the submucosa which can be identified using EUS.
© 2022. Crown.

Entities:  

Keywords:  Disease duration; Dysphagia; Endoscopic ultrasound; Eosinophilic esophagitis; Esophageal wall thickness

Mesh:

Year:  2022        PMID: 35666332     DOI: 10.1007/s10388-022-00924-7

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   3.671


  4 in total

Review 1.  Esophageal motility in eosinophilic esophagitis.

Authors:  A H Weiss; N Iorio; R Schey
Journal:  Rev Gastroenterol Mex       Date:  2015-08-12

2.  Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry.

Authors:  Leticia Martín Martín; Cecilio Santander; Mari Carmen Lopez Martín; Jorge Espinoza-Ríos; Carlos Chavarría-Herbozo; Javier P Gisbert; Ricardo Moreno-Otero
Journal:  J Gastroenterol Hepatol       Date:  2011-09       Impact factor: 4.029

3.  A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums.

Authors:  D A Leiman; B Kochar; S Posner; C Fan; A Patel; O Shaheen; C Y Keller; N T Koutlas; S Eluri; E S Dellon
Journal:  Dis Esophagus       Date:  2018-08-01       Impact factor: 3.429

Review 4.  Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©.

Authors:  Rena Yadlapati; Peter J Kahrilas; Mark R Fox; Albert J Bredenoord; C Prakash Gyawali; Sabine Roman; Arash Babaei; Ravinder K Mittal; Nathalie Rommel; Edoardo Savarino; Daniel Sifrim; André Smout; Michael F Vaezi; Frank Zerbib; Junichi Akiyama; Shobna Bhatia; Serhat Bor; Dustin A Carlson; Joan W Chen; Daniel Cisternas; Charles Cock; Enrique Coss-Adame; Nicola de Bortoli; Claudia Defilippi; Ronnie Fass; Uday C Ghoshal; Sutep Gonlachanvit; Albis Hani; Geoffrey S Hebbard; Kee Wook Jung; Philip Katz; David A Katzka; Abraham Khan; Geoffrey Paul Kohn; Adriana Lazarescu; Johannes Lengliner; Sumeet K Mittal; Taher Omari; Moo In Park; Roberto Penagini; Daniel Pohl; Joel E Richter; Jordi Serra; Rami Sweis; Jan Tack; Roger P Tatum; Radu Tutuian; Marcelo F Vela; Reuben K Wong; Justin C Wu; Yinglian Xiao; John E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2021-01       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.